Myopathies Flashcards
Muscular dystrophies
Duchenne
Becker
FSHD (LandouzyxDéjérine)
Limb-girdle
Myotonic diseases
Myotonic dystrophy type 1
myotonic dystrophy type 2
Congenital myotonia
Metabolic myopathies and clinical presentation
Glicogen storage disease
lipid myopathies
Myoadenilate deaminase deficiency
Mitochondrial
Clinical presentation: slowly progressive myopathies, induced by muscle exercise
Duchenne muscular dystrophy mutation in
Dystrophy gen Xp21
Duchenne. Clinical presentation
Muscle hypertrophy, calf muscles
loss of independent ambulating by age 8 to 12
Contractures, scoliosis
Cardiomyopathy
Respiratory insufficiency
Death at the age of 29
Duchenne treatment
Corticoesteroids
Ataluren
Becker Mutation in
Dystrophy gen Xp21
Becker complications
Contractures, scoliosis, cardiomyopathy, respiratory insufficiency
Ataluren is
treatment for Duchenne and Becker
Facioscapulohumera MD gen affected
Chromosome 4q35. AD
In myotonic dystrophy are affected
Proteins DM1 (for type 1) DM2 (for type 2)
Pompe disease
Glycogen storage disease. GSD type 2
Muscle weakness (hypotonia, Floppy baby, head lag)
elevated plasma creatine kinase, AST an ALT. Increase glycogen.
Delayed motor milestone
Progressive weakening of skeletal muscles
Muscle atrophy (scoliosis, kyphosis, lordosis, scapular winging)
Enzyme McArdle
Myophosphorilase
Treatment of polymyositis
Corticosteroids
Methotrexate
Human immunoglobulines
Pompe’s disease. Early onset
Hypotonia and head lag
No swallowing
Cardiomegaly and cardiomyopathy
Epathomegaly
Liver disorder
Survival without treatment 2 years